Opendata, web and dolomites

ECRAID-Plan SIGNED

European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ECRAID-Plan project word cloud

Explore the words cloud of the ECRAID-Plan project. It provides you a very rough idea of what is the project "ECRAID-Plan" about.

vi    domains    periods    consultation    plan    network    reduce    multisectoral    antimicrobial    months    budget    policies    internal    efforts    commence    governance    business    global    pose    combacte    sharing    serve    funders    sufficient    population    diseases    prepare    pan    permanent    networks    smooth    co    infectious    scientific    cutting    cross    external    regulators    data    complementary    themes    12    reducing    document    joint    commitment    extensive    model    threats    clinical    ids    economies    guiding    transition    continuous    generating    makers    eid    amr    reconciliation    resistance    strengths    interoperabilty    investment    service    health    infrastructures    serious    threat    prevention    infrastructure    weaknesses    start    stakeholders    international    ecraid    24    operations    platform    industry    treatment    stakeholder    id    components    structure    individual    mission    coordinated    diagnosis    policy    inform    rigorous    coordinators    ambition    sustainable   

Project "ECRAID-Plan" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 

Organization address
address: HEIDELBERGLAAN 100
city: UTRECHT
postcode: 3584 CX
website: www.umcutrecht.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙994˙560 €
 EC max contribution 2˙994˙560 € (100%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL (UTRECHT) coordinator 1˙257˙735.00
2    UNIVERSITEIT ANTWERPEN BE (ANTWERPEN) participant 271˙350.00
3    ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK FR (PARIS) participant 265˙150.00
4    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 215˙150.00
5    FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS IT (PADOVA) participant 165˙150.00
6    UNIVERSITE D'AIX MARSEILLE FR (Marseille) participant 163˙275.00
7    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 158˙850.00
8    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 91˙925.00
9    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) participant 83˙850.00
10    ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO IT (ROMA) participant 83˙850.00
11    EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS BE (BRUSSEL) participant 79˙425.00
12    ROBERT KOCH-INSTITUT DE (Berlin) participant 79˙425.00
13    UMEA UNIVERSITET SE (UMEA) participant 79˙425.00

Map

 Project objective

Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ECRAID-PLAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ECRAID-PLAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

DIAMONDS (2020)

Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

Read More  

STARS (2019)

Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

Read More  

HEcoPerMed (2019)

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Read More